Clinical Trial Update: Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intravenous palifosfamide-tris in combination with etoposide and carboplatin in patients with various malignancies; current status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Osteosarcoma
• Ovarian Cancer
• Small Cell Lung Cancer
• Testicular Cancer
• Thymoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Palifosfamide Tris (palifosfamide tris)

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Malignancy, Cancer | Phase 1 | Status: UNKNOWN